Logo image of RWLK

REWALK ROBOTICS LTD (RWLK) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:RWLK - IL0011331076 - Common Stock

1.0501 USD
+0.06 (+6.07%)
Last: 1/29/2024, 8:00:03 PM
1.0798 USD
+0.03 (+2.83%)
After Hours: 1/29/2024, 8:00:03 PM

RWLK Key Statistics, Chart & Performance

Key Statistics
Market Cap63.03M
Revenue(TTM)9.15M
Net Income(TTM)-21.80M
Shares60.02M
Float58.83M
52 Week High1.3
52 Week Low0.56
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.37
PEN/A
Fwd PEN/A
Earnings (Next)02-22 2024-02-22/amc
IPO2014-09-12
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


RWLK short term performance overview.The bars show the price performance of RWLK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30 40 50

RWLK long term performance overview.The bars show the price performance of RWLK in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40

The current stock price of RWLK is 1.0501 USD. In the past month the price increased by 40.9%. In the past year, price increased by 24.35%.

REWALK ROBOTICS LTD / RWLK Daily stock chart

RWLK Latest News, Press Relases and Analysis

RWLK Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.83 224.14B
ISRG INTUITIVE SURGICAL INC 66.61 203.30B
BSX BOSTON SCIENTIFIC CORP 34.43 150.59B
SYK STRYKER CORP 28.18 141.95B
IDXX IDEXX LABORATORIES INC 59.7 60.12B
BDX BECTON DICKINSON AND CO 13.45 55.61B
EW EDWARDS LIFESCIENCES CORP 33.72 50.29B
RMD RESMED INC 25.84 37.34B
GEHC GE HEALTHCARE TECHNOLOGY 17.43 36.44B
DXCM DEXCOM INC 34.12 24.75B
PODD INSULET CORP 71.6 23.02B
ZBH ZIMMER BIOMET HOLDINGS INC 12.05 19.33B

About RWLK

Company Profile

RWLK logo image ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The firm offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. ReWalk designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities, and is custom fitted for each user. ReWalk Rehabilitation is designed for use by paraplegia patients in the clinical rehabilitation environment, where it provides exercise and therapy.

Company Info

REWALK ROBOTICS LTD

3 Hatnufa st. 6th fl., P.O. Box 161

Yokneam 2069203 IL

CEO: Larry Jasinski

Employees: 56

RWLK Company Website

Phone: 97249590123

REWALK ROBOTICS LTD / RWLK FAQ

What does REWALK ROBOTICS LTD do?

ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The firm offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. ReWalk designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities, and is custom fitted for each user. ReWalk Rehabilitation is designed for use by paraplegia patients in the clinical rehabilitation environment, where it provides exercise and therapy.


What is the stock price of REWALK ROBOTICS LTD today?

The current stock price of RWLK is 1.0501 USD. The price increased by 6.07% in the last trading session.


What is the dividend status of REWALK ROBOTICS LTD?

RWLK does not pay a dividend.


What is the ChartMill technical and fundamental rating of RWLK stock?

RWLK has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Where is REWALK ROBOTICS LTD (RWLK) stock traded?

RWLK stock is listed on the Nasdaq exchange.


What is the GICS sector and industry of RWLK stock?

REWALK ROBOTICS LTD (RWLK) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


Can you provide the upcoming earnings date for REWALK ROBOTICS LTD?

REWALK ROBOTICS LTD (RWLK) will report earnings on 2024-02-22, after the market close.


RWLK Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to RWLK. When comparing the yearly performance of all stocks, RWLK is one of the better performing stocks in the market, outperforming 87.06% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

RWLK Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to RWLK. RWLK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RWLK Financial Highlights

Over the last trailing twelve months RWLK reported a non-GAAP Earnings per Share(EPS) of -0.37. The EPS decreased by -27.59% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -31.49%
ROE -42.1%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-44.44%
Sales Q2Q%394.38%
EPS 1Y (TTM)-27.59%
Revenue 1Y (TTM)99.78%

RWLK Forecast & Estimates

7 analysts have analysed RWLK and the average price target is 3.06 USD. This implies a price increase of 191.4% is expected in the next year compared to the current price of 1.0501.

For the next year, analysts expect an EPS growth of -21.12% and a revenue growth 162.79% for RWLK


Analysts
Analysts82.86
Price Target3.06 (191.4%)
EPS Next Y-21.12%
Revenue Next Year162.79%

RWLK Ownership

Ownership
Inst Owners0%
Ins Owners28.31%
Short Float %N/A
Short RatioN/A